What is Haemonetics's total revenue?

Haemonetics (HAE) reported total revenue of $346.35M in Q1 2026.

How has Haemonetics's total revenue changed year-over-year?

Haemonetics's total revenue increased by 4.8% year-over-year, from $330.6M to $346.35M.

What is the long-term trend for Haemonetics's total revenue?

Over 4 years (2022 to 2026), Haemonetics's total revenue has grown at a 7.7% compound annual growth rate (CAGR), from $993.2M to $1.33B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Haemonetics HAE Total Revenue

Total Revenue at other companies

AbbottABT

$11.16B+7.8%

TFX

TeleflexTFX

$548.26M+32.3%

Boston ScientificBSX

$5.2B+11.6%

MedtronicMDT

$9.81B+9.9%

LivaNovaLIVN

$362.26M+14.3%

ICU MedicalICUI

$530.23M-12.3%

Segments

By geography

See full

Europe$52.9M+25.1%

Asia$23.03M-10.0%

Rest of Asia$19.97M-5.6%

Other$3.11M+12.3%

Other Countryor Region$1.81M-63.3%

By segment

See full

Hospital$159.65M+8.0%

Plasma$130.29M+2.8%

Blood Center$56.41M+0.7%

By product

See full

Hospital$287M-0.3%

Plasma$130.29M+2.8%

Blood Center$113.12M-19.6%

Other financials

Income statement

See full

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's total revenue?: Haemonetics (HAE) reported total revenue of $346.35M in Q1 2026.
How has Haemonetics's total revenue changed year-over-year?: Haemonetics's total revenue increased by 4.8% year-over-year, from $330.6M to $346.35M.
What is the long-term trend for Haemonetics's total revenue?: Over 4 years (2022 to 2026), Haemonetics's total revenue has grown at a 7.7% compound annual growth rate (CAGR), from $993.2M to $1.33B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.